Health
5 articles
Boehringer Ingelheim drug slashes liver and belly fat
In Phase 3 trials, Boehringer Ingelheim's experimental obesity drug, survodutide, helped recipients shed up to 17% of their body weight over 76 weeks, crucially preserving muscle mass.
Pfizer's obesity drug shows potential for monthly dosing
Mid-stage study data reveals Pfizer's experimental obesity drug, berobenatide, could achieve significant weight loss with a groundbreaking monthly dosing schedule, a stark contrast to current weekly o
Trump administration removes job protections for NIH officials
The National Institute of Mental Health (NIMH), typically funding nearly 1,000 new research awards annually, is on track to fund only 50 for the entire fiscal year.
Turkey's Hair Transplant Industry 'Hacks' Global Market
A hair transplant procedure costing up to $30,000 in the U.S. can be secured for as little as $3,000 in Turkey, often including travel and accommodation. This price disparity has made Turkey the global leader in hair restoration, effectively 'hacking' the global industry.
FDA advisory panel rejects AstraZeneca breast cancer drug
A U.S. Food and Drug Administration advisory committee voted 3 to 6 against the benefit-risk profile of AstraZeneca's breast cancer drug camizestrant, according to AstraZeneca . This decision creates